22nd Century Group Company Profile (NYSE:XXII)

About 22nd Century Group (NYSE:XXII)

22nd Century Group logo22nd Century Group, Inc. is a plant biotechnology company. The Company is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties; development of X-22, a smoking cessation aid consisting of very low nicotine (VLN) cigarettes; manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes; production of SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA); contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of hemp/cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol (THC), plants with high levels of cannabidiol (CBD), and other non-THC cannabinoids.

Industry, Sector and Symbol:
  • Sector: Industrials
  • Industry: Environmental Biotechnology
  • Sub-Industry: N/A
  • Symbol: NYSE:XXII
  • CUSIP: N/A
  • Web: www.xxiicentury.com/
  • Market Cap: $273.34 million
  • Outstanding Shares: 102,760,000
Average Prices:
  • 50 Day Moving Avg: $2.78
  • 200 Day Moving Avg: $1.95
  • 52 Week Range: $0.81 - $3.50
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -38.00
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $12.56 million
  • Price / Sales: 21.76
  • Book Value: $0.26 per share
  • Price / Book: 10.23
  • EBITDA: ($10,690,000.00)
  • Net Margins: -86.10%
  • Return on Equity: -57.55%
  • Return on Assets: -49.40%
  • Average Volume: 4.35 million shs.
  • Short Ratio: 3.09

Frequently Asked Questions for 22nd Century Group (NYSE:XXII)

What is 22nd Century Group's stock symbol?

22nd Century Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "XXII."

How were 22nd Century Group's earnings last quarter?

22nd Century Group Inc (NYSE:XXII) issued its quarterly earnings results on Tuesday, May, 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $0.01. The firm had revenue of $3.02 million for the quarter. 22nd Century Group had a negative net margin of 86.10% and a negative return on equity of 57.55%. View 22nd Century Group's Earnings History.

When will 22nd Century Group make its next earnings announcement?

22nd Century Group is scheduled to release their next quarterly earnings announcement on Monday, November, 6th 2017. View Earnings Estimates for 22nd Century Group.

Where is 22nd Century Group's stock going? Where will 22nd Century Group's stock price be in 2017?

1 equities research analysts have issued twelve-month price objectives for 22nd Century Group's shares. Their predictions range from $11.50 to $11.50. On average, they expect 22nd Century Group's stock price to reach $11.50 in the next year. View Analyst Ratings for 22nd Century Group.

What are analysts saying about 22nd Century Group stock?

Here are some recent quotes from research analysts about 22nd Century Group stock:

  • 1. According to Zacks Investment Research, "22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York. " (10/18/2017)
  • 2. Chardan Capital analysts commented, "We expect 22nd Century to report Q4 results this week. Our revenue estimate for the quarter is $3.1 million, equivalent to Q3 results. For the full year this results in revenue of $12 million. We expect the company on its earnings call to focus on recent communications with the FDA regarding its PMTA (Premarket Tobacco Product Applications), the MRTP (Modified Risk Tobacco Product) applications and a path forward for X-22. Earlier this month the FDA granted a guidance meeting to discuss X-22 and the ways 22nd Century could attempt to win approval for X-22 as a prescription-based aid for smoking cessation. The company has also received written feedback on the MRTP application for Brand A, the company's very low nicotine (VLN) cigarette. As we progress through the year we expect additional milestones to be reached on 22nd Century's attempt to use its proprietary technology to create VLN products for the smoking cessation market." (3/7/2017)

Are investors shorting 22nd Century Group?

22nd Century Group saw a increase in short interest in September. As of September 29th, there was short interest totalling 7,563,163 shares, an increase of 0.8% from the September 15th total of 7,500,903 shares. Based on an average daily trading volume, of 3,558,908 shares, the short-interest ratio is currently 2.1 days. Currently, 8.8% of the company's stock are short sold.

Who are some of 22nd Century Group's key competitors?

Who are 22nd Century Group's key executives?

22nd Century Group's management team includes the folowing people:

  • Henry Sicignano III, President, Chief Executive Officer, Director
  • John T. Brodfuehrer, Chief Financial Officer, Treasurer
  • Thomas L. James Esq., Vice President, General Counsel, Secretary
  • Paul Rushton Ph.D., Vice President - Plant Biotechnology
  • Michael R. Moynihan Ph.D., Vice President - Research & Development
  • James W. Cornell, Non-Executive Independent Chairman of the Board
  • Nora B. Sullivan, Director
  • Joseph Alexander Dunn Ph.D., Independent Director
  • Richard M. Sanders, Independent Director

How do I buy 22nd Century Group stock?

Shares of 22nd Century Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is 22nd Century Group's stock price today?

One share of 22nd Century Group stock can currently be purchased for approximately $2.66.

MarketBeat Community Rating for 22nd Century Group (NYSE XXII)
Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  90 (Vote Outperform)
Underperform Votes:  85 (Vote Underperform)
Total Votes:  175
MarketBeat's community ratings are surveys of what our community members think about 22nd Century Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for 22nd Century Group (NYSE:XXII) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.50 (332.33% upside)
Consensus Price Target History for 22nd Century Group (NYSE:XXII)
Price Target History for 22nd Century Group (NYSE:XXII)
Analysts' Ratings History for 22nd Century Group (NYSE:XXII)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/16/2017Chardan CapitalBoost Price TargetBuy -> Buy$3.50 -> $11.50N/AView Rating Details
(Data available from 10/22/2015 forward)


Earnings History for 22nd Century Group (NYSE:XXII)
Earnings by Quarter for 22nd Century Group (NYSE:XXII)
Earnings History by Quarter for 22nd Century Group (NYSE XXII)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017($0.02)N/AView Earnings Details
5/10/2016Q1($0.03)($0.04)$3.02 millionViewN/AView Earnings Details
11/9/2015Q3($0.03)($0.04)$2.67 millionViewN/AView Earnings Details
8/4/2015Q215($0.02)($0.02)$1.30 million$2.31 millionViewN/AView Earnings Details
2/6/2015($0.03)($0.09)ViewN/AView Earnings Details
11/14/2014Q314($0.03)($0.05)$0.06 millionViewN/AView Earnings Details
8/14/2014($0.03)($0.03)$0.02 millionViewN/AView Earnings Details
5/2/2014($0.03)($0.09)$0.45 millionViewN/AView Earnings Details
1/30/2014Q4($0.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for 22nd Century Group (NYSE:XXII)
Current Year EPS Consensus Estimate: $-0.10 EPS
Next Year EPS Consensus Estimate: $-0.07 EPS


Dividend History for 22nd Century Group (NYSE:XXII)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for 22nd Century Group (NYSE:XXII)
Insider Trades by Quarter for 22nd Century Group (NYSE:XXII)
Institutional Ownership by Quarter for 22nd Century Group (NYSE:XXII)
Insider Trades by Quarter for 22nd Century Group (NYSE:XXII)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/29/2017Michael Robert MoynihanVPSell50,000$2.67$133,500.00View SEC Filing  
7/31/2017Michael Robert MoynihanVPSell29,532$2.00$59,064.00View SEC Filing  
6/8/2017Michael Robert MoynihanVPSell20,468$2.00$40,936.00View SEC Filing  
10/31/2016Michael Robert MoynihanVPSell100,000$1.28$128,000.00View SEC Filing  
3/29/2016John T BrodfuehrerCFOBuy12,500$0.77$9,625.00View SEC Filing  
11/3/2015Michael Robert MoynihanVPSell50,000$1.40$70,000.00View SEC Filing  
6/30/2015Joseph PandolfinoDirectorSell91,178$0.95$86,619.10View SEC Filing  
12/31/2014Joseph PandolfinoDirectorSell105,124$1.65$173,454.60View SEC Filing  
12/26/2014Joseph PandolfinoDirectorSell41,722$1.54$64,251.88View SEC Filing  
12/22/2014Joseph PandolfinoDirectorSell52,683$1.60$84,292.80View SEC Filing  
12/17/2014Joseph PandolfinoDirectorSell75,768$1.62$122,744.16View SEC Filing  
12/11/2014Joseph PandolfinoDirectorSell67,836$1.65$111,929.40View SEC Filing  
5/9/2014Richard M SandersDirectorBuy20,000$2.23$44,600.00View SEC Filing  
4/23/2014Michael Robert MoynihanVPSell100,000$2.44$244,000.00View SEC Filing  
3/12/2014Joseph PandolfinoCEOSell95,000$5.73$544,350.00View SEC Filing  
12/10/2013Clearwater Partners, LlcMajor ShareholderSell10,000$1.55$15,500.00View SEC Filing  
12/3/2013Clearwater Partners, LlcMajor ShareholderSell10,000$1.35$13,500.00View SEC Filing  
11/19/2013Clearwater Partners, LlcMajor ShareholderSell30,074$1.09$32,780.66View SEC Filing  
11/13/2013Clearwater Partners, LlcMajor ShareholderSell11,826$0.98$11,589.48View SEC Filing  
11/11/2013Clearwater Partners, LlcMajor ShareholderSell7,100$1.03$7,313.00View SEC Filing  
11/7/2013Clearwater Partners, LlcMajor ShareholderSell9,000$1.15$10,350.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for 22nd Century Group (NYSE:XXII)
Latest Headlines for 22nd Century Group (NYSE:XXII)
Loading headlines, please wait.



22nd Century Group (XXII) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.